· NY legislature · 2025-2026

Requires practitioners to discuss certain risks with a patient who is being prescribed a controlled substance or an opioid analgesic

Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.

Sponsor

Linda Rosenthal (D-NY)

Introduced

2025-08-13

Policy area

Health

Latest action

PRINT NUMBER 9010A